The global hydrophilic catheters market size was estimated at USD 2.41 billion in 2025 and is predicted to increase from USD 2.6 billion in 2026 to approximately USD 5.13 billion by 2035, expanding at a CAGR of 7.85% from 2026 to 2035. The market is growing steadily due to rising cases of urinary disorders, an increasing elderly population, and higher demand for comfortable, low-friction catheterization solutions. Technological advancements in catheter coating and expanding use in home healthcare and hospitals are further driving global market adoption.
A hydrophilic catheter is a medical tube coated with a water-attracting layer that becomes slippery when wet, reducing friction during insertion and removal. It is mainly used for intermittent urinary catheterization to improve comfort and reduce the risk of urethral injury and infection. The hydrophilic catheters market is growing due to the increasing prevalence of urinary disorders, the rising geriatric population, and the growing awareness about self-catheterization. These catheters reduce friction, pain, and infection risk, making them preferred in both hospitals and home care settings. Technological improvement in catheter coatings and expanding healthcare infrastructure further support their adoption across developed and emerging regions.
AI can influence the market by enabling smarter product design, predictive analytics for patient needs, and improved clinical decision-making. It can support personalized catheter selection, reduce complications through data-driven insights, and optimize supply chain management. Additionally, AI-powered remote monitoring and digital health platforms can enhance patient compliance and expand home-based care, indirectly increasing the demand for advanced, user-friendly catheter solutions.
| Table | Scope |
| Market Size in 2026 | USD 52.93 Billion |
| Projected Market Size in 2035 | USD 114 Billion |
| CAGR (2026 - 2035) | 7.85% |
| Leading Region | North America by 36% |
| Historical Data | 2020 - 2023 |
| Base Year | 2025 |
| Forecast Period | 2026 - 2035 |
| Measurable Values | USD Millions/Units/Volume |
| Market Segmentation | By Product Type, By Coating Type, By Material, By Indication, By End User, By Distribution Channel, By Region |
| Top Key Players | (C. R. Bard, Inc.) BD, Teleflex Incorporated, B. Braun Melsungen AG, Coloplast A/S, Hollister Incorporated, Arthesys, AngioDynamics, Inc. |
| Segment | Share 2025 (%) |
| Intermittent Catheters | 58% |
| Indwelling (Foley) Catheters | 28% |
| External Catheters | 14% |
The Intermittent Catheters Segment Dominated the Market in 2025
The intermittent catheters segment held a dominant share of 58% in 2025 and is expected to grow at the fastest CAGR of 8.4% in the hydrophilic catheters market during the forecast period due to its lower risk of urinary tract infections compared to indwelling catheters, along with greater patient comfort and ease of self-catheterization. Growing preference for home-based care, increasing prevalence of urinary disorders, and advancements such as hydrophilic coating further boosted adoption, making intermittent catheters the most widely used and preferred product type globally.
The indwelling (Foley) catheters segment held the second-largest share of 28% in 2025 due to its widespread use in hospitals for long-term bladder drainage, especially during surgeries, critical care, and for immobilized or chronically ill patients. Their ability to remain in place for continuous urine drainage reduces the need for frequent insertion. High demand in acute care settings and an aging population further support steady adoption of Foley catheters.
The external catheters segment held a 14% of the hydrophilic catheters market share due to its non-invasive nature and lower risk of urinary tract infections compared to indwelling options. Increasing demand for comfortable, easy-to-use solutions, especially among male patients and urinary incontinence support adoption, rising home healthcare trends, aging population, and improved product design with better adherence and skin-friendly material are further driving market growth globally.
| Segment | Share 2025 (%) |
| Fully Hydrophilic Coated | 52% |
| Pre-lubricated Coated | 31% |
| Antimicrobial Hydrophilic Coated | 17% |
The Fully Hydrophilic Coated Segment Led the Market in 2025 with the Largest Share
The fully hydrophilic coated segment held a dominant share of 52% in 2025 and is expected to grow at the fastest CAGR of 8.6% in the hydrophilic catheters market during the forecast period due to its superior lubrication, which reduces friction, urethral trauma, and discomfort during catheterization. These coatings also lower the risk of urinary tract infections by minimizing bacterial adherence. Growing patient preference for safer, more comfortable options, along with increasing adoption in home healthcare and self-catheterization, has driven strong demand for fully hydrophilic coated catheters.
The pre-lubricated coated segment held the second-largest share of 31% in 2025 due to its convenience and ease of use, eliminating the need for additional lubrication during catheterization. These catheters support quicker, cleaner procedures, making them suitable for both clinical and home settings. Cost-effectiveness compared to fully hydrophilic options and increasing demand for hygienic, ready-to-use products further contribute to their widespread adoption and steady market growth.
The antimicrobial hydrophilic coated segment held a 17% of the hydrophilic catheters market share due to dual benefits of reducing friction and preventing bacterial growth, lowering the risk of urinary tract infections. Increasing awareness about infection control, especially in hospitals and long-term care, is driving demand. Advancements in coating technologies and rising preference for safer, hygiene-focused catheter solutions in both clinical and home settings further support market growth.
| Segment | Share 2025 (%) |
| Urinary Incontinence | 34% |
| Spinal Cord Injuries | 21% |
| Benign Prostatic Hyperplasia (BPH) | 18% |
| Post-Surgical Urinary Retention | 16% |
| Others | 11% |
The Urinary Incontinence Segment Led the Market in 2025 with the Largest Share
The urinary incontinence segment dominated the hydrophilic catheters market with a revenue share of 34% in 2025 due to its high global prevalence, especially among the elderly population and patients with neurological disorders. Increasing awareness, improved rates, and rising demand for effective bladder management solutions drive the use of catheters. Additionally, the growing adoption of home healthcare and the availability of user-friendly catheter products further support the dominance of this segment across both clinical and personal care settings.
The spinal cord injuries segment held the second-largest share of 21% in 2025 and is expected to grow at the fastest CAGR of 8.5% in the market during the forecast period due to the high incidence of neurogenic bladder dysfunction among affected patients requiring long-term catheterization for effective urine management. Consistent need for intermittent or indwelling catheter use drives demand. Additionally, improved survival rates, rehabilitation programs, and increasing access to urological care and assistive devices further support steady growth in this segment.
The benign prostatic hyperplasia (BPH) segment held a 18% of the hydrophilic catheters market share due to the rising aging male populations, as BPH prevalence increases with age. The condition often leads to urinary retention requiring catheterization for effective bladder management. Increasing awareness, early diagnosis, and preference for minimally invasive management options support demand. Additionally, expanding access to urological care and home-based treatment solutions further contributed to steady segment growth.
The post-surgical urinary retention segment held a 16% of the hydrophilic catheters market share due to the rising number of surgical procedures globally, particularly among the aging population. Anesthesia and certain medications often impair bladder function temporarily, increasing the need for catheterization. Growing adoption of minimally invasive surgeries, improved post-operative care, and heightened focus on patient recovery and compliance prevention further drive demand for effective urinary management solutions in this segment.
| Segment | Share 2025 (%) |
| Hospitals | 49% |
| Home Care Settings | 29% |
| Ambulatory Surgical Centers | 13% |
| Long-term Care Facilities | 9% |
The Hospitals Segment Led the Market in 2025 with the Largest Share
The hospitals segment led the hydrophilic catheters market with a share of 49% in 2025 due to the high volume of surgical procedures, emergency care, and critical care cases requiring catheterization. Hospitals serve as primary centers for diagnosis, treatment, and post-operative management, leading to consistent demand. Availability of skilled healthcare professionals, advanced infrastructure, and strict infection control protocols further support extensive catheter use, making hospitals the leading end-user segment globally.
The home care settings segment held the second-largest share of 29% in 2025 and is expected to grow at the fastest CAGR of 8.9% in the market during the forecast period due to the growing preference for at-home treatment and long-term bladder management. Patients with chronic conditions, disabilities, or post-surgical needs increasingly opt for self-catheterization in a comfortable environment. Rising awareness, availability of easy-to-use catheter products, and cost savings compared to hospital stays further support strong adoption of home care settings globally.
The ambulatory surgical centers segment held a 13% of the hydrophilic catheters market share due to the rising shift towards outpatient procedures that require short-term catheterization. These centers offer cost-effective, efficient surgical care with faster patient turnaround compared to hospitals. increasing adoption of minimally invasive surgeries, shorter recovery time, and expanding healthcare infrastructure are driving demand for catheter use in ambulatory settings, supporting the steady growth of this segment.
The long-term care facilities segment held a 9% of the hydrophilic catheters market share due to the rising elderly population and increasing prevalence of chronic conditions requiring continuous bladder management. Patients with limited mobility or neurological disorders often need prolonged catheter use, driving demand. Growing focus on elderly care, improved healthcare infrastructure, and increasing admission to nursing homes and rehabilitation centers further support the steady growth of this segment.
North America dominated the hydrophilic catheters market with a share of 36% in 2025 due to its advanced healthcare infrastructure, high awareness of infection prevention, and strong adoption of innovative medical technology. The region has a high prevalence of urinary disorders and a well-established reimbursement framework supporting catheter use. Additionally, the presence of key market players, growing home healthcare trends, and increased focus on patient comfort and safety further drive regional dominance.
U.S. Market Trends
The U.S. hydrophilic catheters market leads due to its highly advanced healthcare systems, strong reimbursement policies, and high awareness of infection prevention. A large patient pool with urinary disorders and spinal injuries drives consistent demand. Additionally, rapid adoption of innovative catheter technologies, growing preference for home healthcare, and the strong presence of leading medical device companies further strengthen the country’s market leadership.
Asia Pacific captured 22% share in 2025 and is anticipated to grow at the fastest CAGR of 8.8% in the hydrophilic catheters market due to its large patient population, rising prevalence of urological disorders, and improving healthcare infrastructure. Increasing awareness about advanced catheter technologies, expanding access to medical care, and growing healthcare investments support adoption. Additionally, the shift toward home healthcare and the rising aging population across countries like China, India, and Japan further accelerates market growth.
India Market Trends
India is anticipated to grow at the fastest CAGR in the hydrophilic catheters due to its large and aging population, rising prevalence of urological disorders, and increasing healthcare awareness. Expanding healthcare infrastructure, government initiatives, and improved access to medical devices support market growth. Additionally, the growing shift toward home healthcare, cost-effective treatment options, and rising adoption of advanced catheter technologies further accelerate demand across the country.
R&D
Clinical Trials
Patient Support and Services
| Companies | Headquarters | Offerings |
| C. R. Bard, Inc. (BD) | New Jersey, USA | Intermittent hydrophilic catheters, urology devices, and infection-prevention technologies focused on patient safety and ease of use. |
| Teleflex Incorporated | Pennsylvania, USA | Hydrophilic intermittent catheters, urology and critical care devices, emphasizing minimally invasive solutions and improved patient comfort. |
| B. Braun Melsungen AG | Melsungen, Germany | Hydrophilic-coated catheters with advanced biocompatible coatings, urology care products, and hospital-based catheter solutions. |
| Coloplast A/S | Humlebæk, Denmark | Hydrophilic intermittent catheters (e.g., SpeediCath), continence care products, and home-use catheter solutions with strong patient-centric design. |
| Hollister Incorporated | Illinois, USA | Hydrophilic and pre-lubricated catheters, continence care products, and home healthcare solutions focused on comfort and discretion. |
| Arthesys | Barcelona, Spain | Specialty hydrophilic-coated catheters and interventional medical devices with a focus on advanced coating technologies. |
| AngioDynamics, Inc. | New York, USA | Hydrophilic-coated catheters are mainly used for vascular and interventional procedures, along with minimally invasive medical devices |
Strengths
Weaknesses
Opportunities
Threats
By Product Type
By Coating Type
By Material
By Indication
By End User
By Distribution Channel
By Region
Principal Consultant
Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.
Learn more about Shivani Zoting
Reviewed By
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.
Learn more about Aditi Shivarkar
+1 804-441-9344
